Journal article
Validation of a commercially available SARS-CoV-2 serological immunoassay
Abstract
OBJECTIVES: To validate the diagnostic accuracy of a Euroimmun SARS-CoV-2 IgG and IgA immunoassay for COVID-19.
METHODS: In this unmatched (1:2) case-control validation study, we used sera of 181 laboratory-confirmed SARS-CoV-2 cases and 326 controls collected before SARS-CoV-2 emergence. Diagnostic accuracy of the immunoassay was assessed against a whole spike protein-based recombinant immunofluorescence assay (rIFA) by receiver operating …
Authors
Meyer B; Torriani G; Yerly S; Mazza L; Calame A; Arm-Vernez I; Zimmer G; Agoritsas T; Stirnemann J; Spechbach H
Journal
Clinical Microbiology and Infection, Vol. 26, No. 10, pp. 1386–1394
Publisher
Elsevier
Publication Date
October 2020
DOI
10.1016/j.cmi.2020.06.024
ISSN
1198-743X
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AdultAntibodies, ViralArea Under CurveBetacoronavirusCOVID-19COVID-19 TestingCase-Control StudiesChildClinical Laboratory TechniquesCoronavirus InfectionsFemaleHumansImmune SeraImmunoassayImmunoglobulin AImmunoglobulin GMalePandemicsPneumonia, ViralROC CurveSARS-CoV-2Sensitivity and SpecificitySeverity of Illness Index